C14orf93 activity can be modulated by several chemical compounds that influence intracellular signaling pathways. One such compound increases the intracellular levels of cyclic AMP, which is a key secondary messenger in cellular signaling. This elevation in cAMP can lead to the activation of protein kinase A, a kinase that is capable of phosphorylating various substrates, including potentially C14orf93, thus enhancing its functional activity. Similarly, other compounds can act as analogs to physiological molecules or ions that mimic the activation of certain pathways, thereby increasing the likelihood of C14orf93 activation through phosphorylation. This includes analogs resistant to degradation that persistently activate protein kinases, as well as inhibitors of protein phosphatases which would lead to an overall increase in the phosphorylation state of proteins within the cell, potentially affecting C14orf93.
In addition to these mechanisms, C14orf93 can also be indirectly influenced by alterations in intracellular calcium levels, which are modulated by specific ionophores that increase calcium influx into the cytosol. Elevated calcium levels can activate a suite of calcium-dependent protein kinases, which are known to phosphorylate a wide array of targets. If C14orf93 is among these targets, its activity could be significantly upregulated. Furthermore, other compounds function by donating small signaling molecules like nitric oxide, which itself can lead to the activation of specific kinases through the increase of cyclic GMP levels. Additionally, agents that modulate the intracellular concentration of metal ions, such as zinc, can activate signaling cascades that have the potential to impact the phosphorylation status and activity of C14orf93.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
As a diacylglycerol analog, this compound activates protein kinase C (PKC), which could phosphorylate C14orf93 if it is a substrate for PKC, resulting in increased protein activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
This cAMP analog is resistant to degradation by phosphodiesterases and thus can persistently activate PKA, which could potentially increase the phosphorylation and activity of C14orf93. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. If C14orf93 is regulated by phosphorylation, its activity could be enhanced due to reduced dephosphorylation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
A selective PKC inhibitor that might lead to compensatory feedback mechanisms that activate alternate pathways, potentially resulting in increased phosphorylation and activation of C14orf93. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
This calcium ionophore increases intracellular calcium levels, which can activate calcium-dependent protein kinases that may phosphorylate and activate C14orf93. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
A calcium ionophore that raises intracellular calcium levels and could activate calcium-dependent kinases, potentially leading to the activation of C14orf93. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A synthetic beta-adrenergic agonist that increases intracellular cAMP levels, thereby activating PKA which could phosphorylate and increase the activity of C14orf93. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
This compound increases intracellular zinc levels, which can act as a second messenger in various signaling pathways, potentially leading to the activation of C14orf93. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
A cAMP analog that activates PKA, leading to potential increased phosphorylation and activation of C14orf93 if it is regulated by PKA-mediated phosphorylation. |